Editas Medicine, Inc. (EDIT) Q1 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Editas Medicine, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.613 Good morning and welcome to Editas Medicine's first quarter conference call. 00:00:05.613 -- 00:00:08.896 All participants are now in a listen-only mode. 00:00:08.896 -- 00:00:13.278 There will be a question and answer session at the end of this call. 00:00:13.680 -- 00:00:17.963 Please be advised that this call is being recorded at the company's request. 00:00:17.963 -- 00:00:22.327 I would now like to turn the call over to Christy Barnett, Corporate Communications and 00:00:22.327 -- 00:00:25.069 Investor Relations at Editas Medicine. 00:00:25.069 -- 00:00:27.069 Thank 00:00:27.151 -- 00:00:31.813 you, Camilla. Good morning everyone and welcome to our first quarter 2023 conference 00:00:31.813 -- 00:00:33.494 call. 00:00:33.494 -- 00:00:37.916 Earlier this morning, we issued a press release providing our financial results and recent 00:00:37.916 -- 00:00:42.958 corporate updates. A replay of today's call will be available in the investor section 00:00:42.958 -- 00:00:47.520 of our website approximately two hours after its completion. 00:00:47.520 -- 00:00:51.742 After our prepared remarks, we will open the call for Q&A. 00:00:51.742 -- 00:00:56.205 As a reminder, various remarks that we make during this call about the company's future 00:00:56.205 -- 00:01:01.214 expectations plans, and prospects constitute forward-looking statements 00:01:01.214 -- 00:01:06.737 for purposes of the safe harbor provisions under the Private Securities Litigation Reform 00:01:06.737 -- 00:01:09.047 Act of 1995. 00:01:09.439 -- 00:01:14.682 Actual results may differ materially from those indicated by these forward-looking statements 00:01:14.682 -- 00:01:19.765 as a result of various important factors, including those discussed in the risk factors 00...